Director, Value, Evidence & Outcomes Liaison; VEOL – Northeast & East

Role Summary

Director, Value, Evidence & Outcomes Liaison (VEOL) – Northeast & East Central serves as the interface between Arcellx and population-based decision makers, including payers, pathway organizations, health systems, research institutions, and policy makers. The role accelerates patient access and transforms healthcare delivery through HEOR/RWE evidence to support the launch of anito-cel, Arcellx’s lead CAR T-cell therapy for relapsed refractory multiple myeloma.

• Deliver and utilize clinical, value, and outcomes evidence including observational research, comparative effectiveness, and economic data to address customer needs.
• Synthesize, communicate, and translate complex information packages and/or data into transparent, relevant, objective and actionable insights for value-based decision makers.
• Collaborate with population-based decision makers within an assigned geographic ecosystem to understand and address their information needs.
• Develop and execute the RWE/HEOR strategy collaborating with internal and field-based medical and commercial partners to deliver outstanding customer experiences.
• Share expertise with customers as their trusted resource on topics related to disease state, Arcellx and competitor products, health outcomes research, quality measures, healthcare policy, technology assessment, economic dynamics, and real-world evidence.
• Establish valued relationships with decision makers within assigned accounts at hospital and payer levels.
• Build and maintain understanding of access landscape, including formulary inclusion, pathway development, payer medical policy coverage, and emerging competitive trends.
• Collaborate with relevant internal stakeholders to incorporate access insights into account planning.
• Apply knowledge of clinical, analytic, environmental, and account-level considerations to facilitate mutually beneficial research collaborations.
• Frequently share customer insights, evidence gaps, environmental trends, and stakeholder evidence needs internally to influence evidence generation and other strategic efforts.
• Build proactive, RWE/HEOR relationships that lead to innovative collaborations.
• Maintain deep market and customer knowledge in an increasingly complex and dynamic healthcare ecosystem.
• Stay abreast of emerging science, environmental trends, healthcare policy, and regulatory actions relevant to US value-based decision-makers.
• Serve as a knowledgeable resource for customers and internal partners on relevant disease states and therapeutic landscapes, HEOR and RWE, value-based care, the payer perspective, access/reimbursement policy landscape, and value assessment in the US.

• Advanced degree (Pharm
  
  D, MD, PhD, MS, MSN, MPH) and 7+ years of experience in a scientific or health-related field, including oncology/hematology experience and field-based customer-facing roles in industry.
• Deep understanding of the US healthcare system and US value-based decision makers.
• Ability to analyze and effectively communicate study findings on a range of clinical and HEOR topics.
• Strong comprehension and communication skills, including the ability to translate and present complex scientific information in a clear, concise manner.
• Experience working with or supporting value-based decision makers.
• Experience in data analytics and/or HEOR research/application.
• Demonstrated expertise in HEOR (including observational and pharmacoeconomic research) and value assessment which may include experience using real-world data, AMCP Dossiers, FDAMA 114, and pharmacoeconomic models.
• This position is based in the field and requires about 50% travel (car and plane) to cover the assigned geography.

• Candidates must reside in their assigned territory. States in this territory include: NJ, NY, CT, RI, MA, VT, NH, ME, TN, KY, WV, VA, PA, MD, DC, DE.